Ertugliflozin Capsule

Ertugliflozin functions as a highly selective SGLT2 inhibitor that leverages a therapeutic synergy between renal glucose filtration and inhibited reabsorption to provide robust glycemic control through an insulin-independent mechanism. The capsule delivery system is engineered to optimize the solubility and uniform release of the active ingredient, ensuring consistent bioavailability and a predictable pharmacokinetic profile for the patient. This sophisticated formulation provides a significant clinical